Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension.
Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP, Czerwiński E, Krieg MA, Man Z, Mellström D, Radominski SC, Reginster JY, Resch H, Román Ivorra JA, Roux C, Vittinghoff E, Austin M, Daizadeh N, Bradley MN, Grauer A, Cummings SR, Bone HG.
Papapoulos S, et al. Among authors: roman ivorra ja.
J Bone Miner Res. 2012 Mar;27(3):694-701. doi: 10.1002/jbmr.1479.
J Bone Miner Res. 2012.
PMID: 22113951
Free PMC article.
Clinical Trial.